Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

International MG/COVID-19 Working Group

doi:10.1016/j.jns.2020.116803

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

International MG/COVID-19 Working Group

Immunology and Immunotherapy

Research output: Contribution to journal › Article › peer-review

55 Citations (Scopus)

Original language	English
Pages (from-to)	116803
Journal	Journal of the Neurological Sciences
Volume	412
DOIs	https://doi.org/10.1016/j.jns.2020.116803
Publication status	Published - 15 May 2020

Keywords

Betacoronavirus
COVID-19
Clinical Trials as Topic
Coronavirus Infections/complications
Disease Management
Disease Susceptibility
Humans
Immunoglobulins, Intravenous/therapeutic use
Immunologic Factors/therapeutic use
Immunosuppressive Agents/therapeutic use
Immunotherapy
Lambert-Eaton Myasthenic Syndrome/complications
Myasthenia Gravis/complications
Pandemics
Plasma Exchange
Pneumonia, Viral/complications
SARS-CoV-2
Vaccines

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jns.2020.116803

Cite this

@article{f2812401cf0149dea55b47255b1650c3,

title = "Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic",

keywords = "Betacoronavirus, COVID-19, Clinical Trials as Topic, Coronavirus Infections/complications, Disease Management, Disease Susceptibility, Humans, Immunoglobulins, Intravenous/therapeutic use, Immunologic Factors/therapeutic use, Immunosuppressive Agents/therapeutic use, Immunotherapy, Lambert-Eaton Myasthenic Syndrome/complications, Myasthenia Gravis/complications, Pandemics, Plasma Exchange, Pneumonia, Viral/complications, SARS-CoV-2, Vaccines",

author = "{International MG/COVID-19 Working Group} and Saiju Jacob and Srikanth Muppidi and Amanda Guidon and Jeffrey Guptill and Michael Hehir and Howard, {James F} and Isabel Illa and Renato Mantegazza and Hiroyuki Murai and Kimiaki Utsugisawa and John Vissing and Heinz Wiendl and Nowak, {Richard J}",

year = "2020",

month = may,

day = "15",

doi = "10.1016/j.jns.2020.116803",

language = "English",

volume = "412",

pages = "116803",

journal = "Journal of the Neurological Sciences",

issn = "0022-510X",

publisher = "Elsevier",

}

TY - JOUR

T1 - Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

AU - International MG/COVID-19 Working Group

AU - Jacob, Saiju

AU - Muppidi, Srikanth

AU - Guidon, Amanda

AU - Guptill, Jeffrey

AU - Hehir, Michael

AU - Howard, James F

AU - Illa, Isabel

AU - Mantegazza, Renato

AU - Murai, Hiroyuki

AU - Utsugisawa, Kimiaki

AU - Vissing, John

AU - Wiendl, Heinz

AU - Nowak, Richard J

PY - 2020/5/15

Y1 - 2020/5/15

KW - Betacoronavirus

KW - COVID-19

KW - Clinical Trials as Topic

KW - Coronavirus Infections/complications

KW - Disease Management

KW - Disease Susceptibility

KW - Humans

KW - Immunoglobulins, Intravenous/therapeutic use

KW - Immunologic Factors/therapeutic use

KW - Immunosuppressive Agents/therapeutic use

KW - Immunotherapy

KW - Lambert-Eaton Myasthenic Syndrome/complications

KW - Myasthenia Gravis/complications

KW - Pandemics

KW - Plasma Exchange

KW - Pneumonia, Viral/complications

KW - SARS-CoV-2

KW - Vaccines

U2 - 10.1016/j.jns.2020.116803

DO - 10.1016/j.jns.2020.116803

M3 - Article

C2 - 32247193

SN - 0022-510X

VL - 412

SP - 116803

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

ER -